Clinical Trial Update: Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years [Phase 3]

View source ↗

Summary

Phase 3 trial update on thalidomide for symptomatic newly diagnosed multiple myeloma in patients over 65.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Grupo de Estudos Multicentricos em Onco-Hematologia | Conditions: Multiple Myeloma | Phase 3 | Status: UNKNOWN